{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T14:44:46Z","timestamp":1783003486986,"version":"3.54.5"},"reference-count":169,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81803120"],"award-info":[{"award-number":["81803120"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82103712"],"award-info":[{"award-number":["82103712"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473507"],"award-info":[{"award-number":["82473507"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2021SYPDRC025"],"award-info":[{"award-number":["2021SYPDRC025"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.lfs.2026.124359","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T16:49:04Z","timestamp":1774630144000},"page":"124359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["LAG-3 at the crossroads: A context-dependent regulator of Tregs and autoimmunity inflammatory disorders"],"prefix":"10.1016","volume":"394","author":[{"given":"Zengyang","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuling","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2026.124359_bb0005","first-page":"11","article-title":"Risk of Inflammatory Central Nervous System Diseases After Tumor Necrosis Factor\u2013Inhibitor Treatment for Autoimmune Diseases","volume":"81","author":"Xie Wenhui","year":"2024","journal-title":"JAMA Neurology"},{"key":"10.1016\/j.lfs.2026.124359_bb0010","first-page":"23","article-title":"Predicting autoimmune diseases: a comprehensive review of classic biomarkers and advances in artificial intelligence","author":"Alvaro","year":"2024","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.lfs.2026.124359_bb0015","first-page":"20","article-title":"The roles of adenosine deaminase in autoimmune diseases","author":"Gao","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.lfs.2026.124359_bb0020","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/s41586-022-05052-x","article-title":"RNA editing underlies genetic risk of common inflammatory diseases","volume":"608","author":"Li","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2026.124359_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01525","article-title":"The role of epigenetics in autoimmune\/inflammatory disease","volume":"10","author":"Surace","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2026.124359_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2024.117352","article-title":"Environmental triggers and future risk of developing autoimmune diseases: molecular mechanism and network toxicology analysis of bisphenol a","volume":"288","author":"Hong","year":"2024","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.lfs.2026.124359_bb0035","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/annrheumdis-2019-216794","article-title":"Functional genomics of autoimmune diseases","volume":"80","author":"Suzuki","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.lfs.2026.124359_bb0040","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s00125-022-05763-w","article-title":"Smoking, use of smokeless tobacco, HLA genotypes and incidence of latent autoimmune diabetes in adults","volume":"66","author":"Edstorp","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/j.lfs.2026.124359_bb0045","first-page":"9","article-title":"Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders. Signal transduction and targeted","author":"Song","year":"2024","journal-title":"Therapy"},{"key":"10.1016\/j.lfs.2026.124359_bb0050","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41581-023-00720-1","article-title":"Pathogenesis of autoimmune disease","volume":"19","author":"Pisetsky","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.lfs.2026.124359_bb0055","first-page":"22","article-title":"A global assessment of incidence trends of autoimmune diseases from 1990 to 2019 and predicted changes to 2040","author":"Li","year":"2023","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.lfs.2026.124359_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103236","article-title":"Autoimmune pre-disease","volume":"22","author":"Bieber","year":"2023","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.lfs.2026.124359_bb0065","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.immuni.2023.01.004","article-title":"Principles of regulatory T cell function","volume":"56","author":"Dikiy","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.lfs.2026.124359_bb0070","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1016\/j.immuni.2024.07.010","article-title":"Transcription factor Ikzf1 associates with Foxp3 to repress gene expression in Treg cells and limit autoimmunity and anti-tumor immunity","volume":"57","author":"Ichiyama","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.lfs.2026.124359_bb0075","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.it.2025.06.007","article-title":"Breaking tolerance: an update of Treg dysfunction in autoimmunity","volume":"46","author":"Cheru","year":"2025","journal-title":"Trends Immunol."},{"key":"10.1016\/j.lfs.2026.124359_bb0080","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.immuni.2019.01.020","article-title":"Human FOXP3+ regulatory T cell heterogeneity and function in autoimmunity and Cancer","volume":"50","author":"Wing","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.lfs.2026.124359_bb0085","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1038\/s41423-021-00785-7","article-title":"CD98-induced CD147 signaling stabilizes the Foxp3 protein to maintain tissue homeostasis","volume":"18","author":"Geng","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.lfs.2026.124359_bb0090","first-page":"7","article-title":"Tregs in visceral adipose tissue up-regulate circadian-clock expression to promote fitness and enforce a diurnal rhythm of lipolysis","author":"Xiao","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.lfs.2026.124359_bb0095","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/cr.2016.151","article-title":"Tregs in cancer immunotherapy","volume":"27","author":"Tanaka","year":"2016","journal-title":"Cell Res."},{"key":"10.1016\/j.lfs.2026.124359_bb0100","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev-immunol-042718-041717","article-title":"Tregs and human disease","volume":"38","author":"Sakaguchi","year":"2020","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.lfs.2026.124359_bb0105","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2023739118","article-title":"Treg-expressed CTLA-4 depletes CD80\/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells","volume":"118","author":"Tekguc","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.lfs.2026.124359_bb0110","first-page":"25","article-title":"Selective depletion of CCR8+Treg cells enhances the antitumor immunity of cytotoxic T cells in lung Cancer by dendritic cells","volume":"20","author":"Peixin Chen","year":"2025","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lfs.2026.124359_bb0115","doi-asserted-by":"crossref","DOI":"10.1172\/JCI169365","article-title":"USP47 inhibits m6A-dependent c-Myc translation to maintain regulatory T cell metabolic and functional homeostasis","volume":"133","author":"Wang","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2026.124359_bb0120","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/s41586-021-03231-w","article-title":"AIM2 in Tregs restrains autoimmune diseases","volume":"591","author":"Chou","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2026.124359_bb0125","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1016\/j.cell.2021.05.028","article-title":"A local regulatory T cell feedback circuit maintains immune homeostasis by pruning self-activated T cells","volume":"184","author":"Wong","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2026.124359_bb0130","first-page":"7","article-title":"Caspase-8 has dual roles in regulatory T cell homeostasis balancing immunity to infection and collateral inflammatory damage","author":"Charis","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.lfs.2026.124359_bb0135","first-page":"8","article-title":"Lung tumor\u2013infiltrating Treghave divergent transcriptional profiles and function linked to checkpoint blockade response","author":"Dykema","year":"2023","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.lfs.2026.124359_bb0140","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature14292","article-title":"Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer","volume":"520","author":"Twyman-Saint Victor","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2026.124359_bb0145","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41577-019-0218-4","article-title":"Tumour-intrinsic resistance to immune checkpoint blockade","volume":"20","author":"Kalbasi","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.lfs.2026.124359_bb0150","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41590-024-02027-0","article-title":"Efficacy of CTLA-4 checkpoint therapy is dependent on IL-21 signaling to mediate cytotoxic reprogramming of PD-1+CD8+ T cells","volume":"26","author":"Zhang","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.lfs.2026.124359_bb0155","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2102849118","article-title":"Differential effects of PD-1 and CTLA-4 blockade on the melanoma-reactive CD8 T cell response","volume":"118","author":"Gangaev","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.lfs.2026.124359_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102590","article-title":"Immune checkpoint inhibitors-induced autoimmunity: the impact of gender","volume":"19","author":"Triggianese","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.lfs.2026.124359_bb0165","doi-asserted-by":"crossref","DOI":"10.1172\/JCI189074","article-title":"CTLA-4 blockade shifts the B cell repertoire toward autoimmunity","volume":"135","author":"\u00c7akan","year":"2025","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2026.124359_bb0170","first-page":"12","article-title":"PD-1 agonism by anti-CD80 inhibits T cell activation and alleviates autoimmunity","volume":"23","author":"Daisuke Sugiura","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.lfs.2026.124359_bb0175","first-page":"12","article-title":"Advances in LAG3 cancer immunotherapeutics","volume":"11","author":"Kieran Adam","year":"2025","journal-title":"Trends Cancer"},{"key":"10.1016\/j.lfs.2026.124359_bb0180","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-019-1091-2","article-title":"Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4","volume":"18","author":"Qin","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.lfs.2026.124359_bb0185","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/s41590-022-01238-7","article-title":"LAG3 ectodomain structure reveals functional interfaces for ligand and antibody recognition","volume":"23","author":"Ming","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.lfs.2026.124359_bb0190","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1016\/j.cell.2025.06.004","article-title":"Proximity between LAG-3 and the T cell receptor guides suppression of T cell activation and autoimmunity","volume":"188","author":"Du","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2026.124359_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107241","article-title":"The immune checkpoint receptor LAG3: structure, function, and target for cancer immunotherapy","volume":"300","author":"Mariuzza","year":"2024","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2026.124359_bb0200","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1016\/j.cell.2025.02.014","article-title":"Ligand-induced ubiquitination unleashes LAG3 immune checkpoint function by hindering membrane sequestration of signaling motifs","volume":"188","author":"Jiang","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2026.124359_bb0205","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.immuni.2018.07.007","article-title":"LAG3+ Tregs restrain Interleukin-23-producing CX3CR1+ gut-resident macrophages during group 3 innate lymphoid cell-driven colitis","volume":"49","author":"Bauch\u00e9","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.lfs.2026.124359_bb0210","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1016\/j.immuni.2024.08.008","article-title":"Inhibitory co-receptor Lag3 supports Foxp3+ regulatory T cell function by restraining Myc-dependent metabolic programming","volume":"57","author":"Kim","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.lfs.2026.124359_bb0215","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.615317","article-title":"LAG3\u2019s enigmatic mechanism of action","volume":"11","author":"Graydon","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2026.124359_bb0220","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adk3702","article-title":"The response to anti\u2013PD-1 and anti\u2013LAG-3 checkpoint blockade is associated with regulatory T cell reprogramming","volume":"17","author":"Rolig","year":"2025","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.lfs.2026.124359_bb0225","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.4049\/jimmunol.1800898","article-title":"Cutting edge: IL-27 attenuates autoimmune Neuroinflammation via regulatory T cell\/Lag3\u2013dependent but IL-10\u2013independent mechanisms in vivo","volume":"202","author":"Kim","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2026.124359_bb0230","doi-asserted-by":"crossref","DOI":"10.1093\/cei\/uxae066","article-title":"Exhausted lag-3+ CD4+ T cells are increased in pediatric inflammatory bowel disease","volume":"219","author":"Schnell","year":"2025","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.lfs.2026.124359_bb0235","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/ecco-jcc\/jjaa054","article-title":"Lymphocyte activation gene (LAG)-3 is associated with mucosal inflammation and disease activity in ulcerative colitis","volume":"14","author":"Slevin","year":"2020","journal-title":"J. Crohn\u2019s Colitis"},{"key":"10.1016\/j.lfs.2026.124359_bb0240","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1016\/j.cell.2024.06.036","article-title":"Blockade of LAG-3 and PD-1 leads to co-expression of cytotoxic and exhaustion gene modules in CD8+ T cells to promote antitumor immunity","volume":"187","author":"Cillo","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2026.124359_bb0245","first-page":"44","article-title":"A capsular polysaccharide from a healthy human microbiota member activates a lag-3-NK cell axis to restrain colon cancer and augment immunotherapy","author":"Weis","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.lfs.2026.124359_bb0250","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.4049\/jimmunol.0800185","article-title":"LAG-3 regulates Plasmacytoid dendritic cell homeostasis","volume":"182","author":"Workman","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2026.124359_bb0255","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-025-02370-2","article-title":"Single-cell transcriptome reveals the reprogramming of immune microenvironment during the transition from MASH to HCC","volume":"24","author":"Huang","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.lfs.2026.124359_bb0260","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/s41586-023-06231-0","article-title":"B-cell-specific checkpoint molecules that regulate anti-tumour immunity","volume":"619","author":"Bod","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2026.124359_bb0265","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/s41590-023-01569-z","article-title":"LAG-3 as the third checkpoint inhibitor","volume":"24","author":"Aggarwal","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.lfs.2026.124359_bb0270","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202401639R","article-title":"LAG-3\u2014an incompletely understood target in cancer therapy","volume":"38","author":"Leitner","year":"2024","journal-title":"FASEB J."},{"key":"10.1016\/j.lfs.2026.124359_bb0275","article-title":"Crystal structure of the human LAG-3","volume":"9","author":"Jan Petersen","year":"2024","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.lfs.2026.124359_bb0280","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.immuni.2022.03.013","article-title":"Binding of LAG-3 to stable peptide-MHC class II limits T cell function and suppresses autoimmunity and anti-cancer immunity","volume":"55","author":"Maruhashi","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.lfs.2026.124359_bb0285","first-page":"43","article-title":"Indirect suppression of CD4 T cell activation through LAG-3-mediated trans-endocytosis of MHC class II","author":"Ei Wakamatsu","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.lfs.2026.124359_bb0290","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/s41590-018-0217-9","article-title":"LAG-3 inhibits the activation of CD4+ T cells that recognize stable pMHCII through its conformation-dependent recognition of pMHCII","volume":"19","author":"Maruhashi","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.lfs.2026.124359_bb0295","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.immuni.2016.05.001","article-title":"Lag-3, Tim-3, and TIGIT: co-inhibitory receptors with specialized functions in immune regulation","volume":"44","author":"Anderson Ana","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.lfs.2026.124359_bb0300","doi-asserted-by":"crossref","DOI":"10.1172\/JCI164809","article-title":"Single-cell characterization of anti\u2013LAG-3 and anti\u2013PD-1 combination treatment in patients with melanoma","volume":"133","author":"Huuhtanen","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2026.124359_bb0305","first-page":"5","article-title":"Sequencing-based approach identified three new susceptibility loci for psoriasis. Nature","author":"Sheng","year":"2014","journal-title":"Communications"},{"key":"10.1016\/j.lfs.2026.124359_bb0310","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.cell.2018.11.010","article-title":"Fibrinogen-like protein 1 is a major immune inhibitory ligand of LAG-3","volume":"176","author":"Wang","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2026.124359_bb0315","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1158\/0008-5472.CAN-13-2690","article-title":"LSECtin expressed on melanoma cells promotes tumor progression by inhibiting antitumor T-cell responses","volume":"74","author":"Xu","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2026.124359_bb0320","article-title":"Structural insights reveal interplay between LAG-3 homodimerization, ligand binding, and function","volume":"121","author":"John","year":"2024","journal-title":"Proc. of the Natl. Acad. of Sci."},{"key":"10.1016\/j.lfs.2026.124359_bb0325","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.it.2003.10.001","article-title":"LAG-3: a regulator of T-cell and DC responses and its use in therapeutic vaccination","volume":"24","author":"Triebel","year":"2003","journal-title":"Trends Immunol."},{"key":"10.1016\/j.lfs.2026.124359_bb0330","first-page":"4","article-title":"Cutting edge molecular analysis of the negative regulatory function of lymphocyte activation Gene-3","volume":"169","author":"Creg","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2026.124359_bb0335","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/sj.emboj.7601520","article-title":"Metalloproteases regulate T-cell proliferation and effector function via LAG-3","volume":"26","author":"Li","year":"2007","journal-title":"EMBO J."},{"key":"10.1016\/j.lfs.2026.124359_bb0340","first-page":"5","article-title":"Shed it, and help\u2014LAG3 cleavage drives conventional CD4+ T cells to overcome resistance to PD-1 immunotherapy","author":"Lea Seidel","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.lfs.2026.124359_bb0345","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jid.2024.10.606","article-title":"Role of ADAM10\/17-mediated cleavage of LAG3 in the impairment of immunosuppression in psoriasis","volume":"145","author":"Yu","year":"2025","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.lfs.2026.124359_bb0350","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1096\/fasebj.10.7.8635694","article-title":"Expression and release of LAG-3-encoded protein by human CD4+ T cells are associated with IFN-\u03b3 production","volume":"10","author":"Annunziato","year":"1996","journal-title":"FASEB J."},{"key":"10.1016\/j.lfs.2026.124359_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2024.103278","article-title":"Soluble form of immune checkpoints in autoimmune diseases","volume":"147","author":"Yuan","year":"2024","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.lfs.2026.124359_bb0360","first-page":"9","article-title":"Serum level of soluble lymphocyte-activation gene 3 is increased in patients with rheumatoid arthritis","volume":"17","author":"Nayyereh Saadati","year":"2020","journal-title":"Iran. J. Immunol."},{"key":"10.1016\/j.lfs.2026.124359_bb0365","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-023-03073-z","article-title":"Lymphocyte activation gene 3 is increased and affects cytokine production in rheumatoid arthritis","volume":"25","author":"Pedersen","year":"2023","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.lfs.2026.124359_bb0370","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.2337\/db11-1591","article-title":"Modulation of Redox Balance Leaves Murine Diabetogenic TH1 T Cells \u201cLAG-3-ing\u201d Behind","volume":"61","author":"Delmastro","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.lfs.2026.124359_bb0375","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1229341","article-title":"Analysis of the mechanisms regulating soluble PD-1 production and function in human NK cells","volume":"14","author":"Mariotti","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2026.124359_bb0380","first-page":"15","article-title":"Thermal-responsive activation of engineered bacteria to trigger antitumor immunity post microwave ablation therapy. Nature","author":"Wu","year":"2024","journal-title":"Communications"},{"key":"10.1016\/j.lfs.2026.124359_bb0385","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/cmi.2016.23","article-title":"Novel exosome-targeted T-cell-based vaccine counteracts T-cell anergy and converts CTL exhaustion in chronic infection via CD40L signaling through the mTORC1 pathway","volume":"14","author":"Wang","year":"2016","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.lfs.2026.124359_bb0390","first-page":"13","article-title":"Defining human Tregs beyond FOXP3: the need to combine phenotype with function","author":"Gootjes","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.lfs.2026.124359_bb0395","first-page":"9","article-title":"CD4+CD25high regulatory cells in human peripheral blood","volume":"167","author":"Clare Baecher-Allan","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2026.124359_bb0400","first-page":"6","article-title":"A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis","volume":"389","author":"Herve\u00c2 Groux","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2026.124359_bb0405","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nm.3179","article-title":"Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells","volume":"19","author":"Gagliani","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2026.124359_bb0410","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1016\/j.jid.2018.05.021","article-title":"Proportion of CD4+CD49b+LAG-3+ type 1 Tregs in the blood of psoriasis patients inversely correlates with psoriasis area and severity index","volume":"138","author":"Kim","year":"2018","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.lfs.2026.124359_bb0415","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202149775","article-title":"Eomesodermin-expressing type 1 regulatory (EOMES+Tr1)-like T cells: basic biology and role in immune-mediated diseases","volume":"53","author":"Geginat","year":"2023","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.lfs.2026.124359_bb0420","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-024-03278-w","article-title":"Regulatory T and B cells in pediatric Henoch\u2013Sch\u00f6nlein purpura: friends or foes?","volume":"26","author":"Filleron","year":"2024","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.lfs.2026.124359_bb0425","first-page":"7","article-title":"Th3 cells in peripheral tolerance. II. TGF-beta-transgenic Th3 cells rescue IL-2-deficient mice from autoimmunity","volume":"178","author":"Yijun Carrier","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2026.124359_bb0430","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jaut.2016.09.005","article-title":"Identification of tonsillar CD4+CD25\u2212LAG3+ T cells as naturally occurring IL-10-producing Tregs in human lymphoid tissue","volume":"76","author":"Sumitomo","year":"2017","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.lfs.2026.124359_bb0435","doi-asserted-by":"crossref","DOI":"10.1186\/s12929-017-0391-3","article-title":"Tregs induced by B cells: a novel subpopulation of Tregs","volume":"24","author":"Chien","year":"2017","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.lfs.2026.124359_bb0440","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/1440-1681.12656","article-title":"Inhibition of CD8+ T cells and elimination of myeloid cells by CD4+ Foxp3\u2212 T regulatory type 1 cells in acute respiratory distress syndrome","volume":"43","author":"Li","year":"2016","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.lfs.2026.124359_bb0445","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-017-1309-x","article-title":"Interleukin-10-producing LAG3+ Tregs are associated with disease activity and abatacept treatment in rheumatoid arthritis","volume":"19","author":"Nakachi","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.lfs.2026.124359_bb0450","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1084\/jem.20100466","article-title":"PD-1 and LAG-3 inhibitory co-receptors act synergistically to prevent autoimmunity in mice","volume":"208","author":"Okazaki","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.lfs.2026.124359_bb0455","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1016\/j.cell.2024.07.016","article-title":"LAG-3 and PD-1 synergize on CD8+ T cells to drive T cell exhaustion and hinder autocrine IFN-\u03b3-dependent anti-tumor immunity","volume":"187","author":"Andrews","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2026.124359_bb0460","first-page":"10","article-title":"Dysfunctional blood and target tissue CD4+CD25high Tregs in psoriasis mechanism underlying unrestrained pathogenic effector T cell proliferation","volume":"174","author":"Hideaki Sugiyama","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2026.124359_bb0465","article-title":"Serum amyloid A1\u2013induced intrahepatic regulatory T-cell dysfunction drives autoimmune hepatitis progression","author":"Wang","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2026.124359_bb0470","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.cmet.2020.03.004","article-title":"Glutathione restricts serine metabolism to preserve regulatory T cell function","volume":"31","author":"Kurniawan","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.lfs.2026.124359_bb0475","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.jaci.2021.04.021","article-title":"Single-cell transcriptomics applied to emigrating cells from psoriasis elucidate pathogenic versus regulatory immune cell subsets","volume":"148","author":"Kim","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.lfs.2026.124359_bb0480","article-title":"Epstein Barr virus-induced 3 (EBI3) together with IL-12 negatively regulates T helper 17-mediated immunity to listeria monocytogenes infection","volume":"9","author":"Gaffen","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.lfs.2026.124359_bb0485","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41423-021-00798-2","article-title":"A novel cytokine consisting of the p40 and EBI3 subunits suppresses experimental autoimmune arthritis via reciprocal regulation of Th17 and Treg cells","volume":"19","author":"Lee","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.lfs.2026.124359_bb0490","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.imlet.2019.12.003","article-title":"IL-33 changes CD25hi Tregs to Th17 cells through a dendritic cell-mediated pathway","volume":"218","author":"Park","year":"2020","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.lfs.2026.124359_bb0495","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nature22360","article-title":"Stability and function of Tregs expressing the transcription factor T-bet","volume":"546","author":"Levine","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2026.124359_bb0500","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1621396","article-title":"Treg cell plasticity as a driver of inflammation in spondyloarthritis and psoriasis","volume":"16","author":"Ortega-Mejia","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2026.124359_bb0505","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.trecan.2023.07.015","article-title":"Modulating Treg stability to improve cancer immunotherapy","volume":"9","author":"Kang","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.lfs.2026.124359_bb0510","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01619","article-title":"CD4+CD25+LAG3+ T cells with a feature of Th17 cells associated with systemic lupus erythematosus disease activity","volume":"10","author":"Kato","year":"2019","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.lfs.2026.124359_bb0515","article-title":"Human memory FOXP3+ Tregs secrete IL-17 ex vivo and constitutively express the T(H)17 lineage-specific transcription factor RORgamma t","volume":"106","author":"Maha Ayyoub","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.lfs.2026.124359_bb0520","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1182\/blood-2008-01-133967","article-title":"Human CD25highFoxp3pos Tregs differentiate into IL-17\u2013producing cells","volume":"112","author":"Koenen","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2026.124359_bb0525","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.smim.2013.10.009","article-title":"The plasticity of human Treg and Th17 cells and its role in autoimmunity","volume":"25","author":"Kleinewietfeld","year":"2013","journal-title":"Semin. Immunol."},{"issue":"6","key":"10.1016\/j.lfs.2026.124359_bb0530","article-title":"Identification of IL-17-producing FOXP3 Tregs in humans","volume":"106","author":"Kui Shin Voo","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.lfs.2026.124359_bb0535","first-page":"10","article-title":"IL-17\u2013producing human peripheral Tregs retain suppressive function","volume":"113","author":"Ga\u00eblle Beriou","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2026.124359_bb0540","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1182\/blood-2012-08-443473","article-title":"CD161 defines the subset of FoxP3+ T cells capable of producing proinflammatory cytokines","volume":"121","author":"Pesenacker","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2026.124359_bb0545","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/cei.12905","article-title":"ROR\u03b3t expression in Tregs promotes systemic lupus erythematosus via IL-17 secretion, alteration of Treg phenotype and suppression of Th2 responses","volume":"188","author":"Kluger","year":"2017","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.lfs.2026.124359_bb0550","article-title":"Elevated levels of CD4+CD25+FoxP3+ T cells in systemic sclerosis patients contribute to the secretion of IL-17 and immunosuppression dysfunction","volume":"8","author":"Zheng","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2026.124359_bb0555","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1038\/jid.2011.139","article-title":"Foxp3+ Tregs of psoriasis patients easily differentiate into IL-17A-producing cells and are found in Lesional skin","volume":"131","author":"Jorn Bovenschen","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.lfs.2026.124359_bb0560","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/brain\/awz012","article-title":"Gut microbiota-dependent CCR9+CD4+ T cells are altered in secondary progressive multiple sclerosis","volume":"142","author":"Kadowaki","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.lfs.2026.124359_bb0565","first-page":"5","article-title":"Tregs that co-express ROR\u03b3t and FOXP3 are pro-inflammatory and immunosuppressive and expand in human pancreatic cancer","author":"Chellappa","year":"2016","journal-title":"OncoImmunology"},{"key":"10.1016\/j.lfs.2026.124359_bb0570","doi-asserted-by":"crossref","DOI":"10.1002\/art.70125","article-title":"Biological\/targeted synthetic DMARDs do not arrest bone loss in patients with rheumatoid arthritis: a long-term multicenter observational study","author":"Aritomi","year":"2026","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.lfs.2026.124359_bb0575","first-page":"15","article-title":"Rheumatoid arthritis","volume":"376","author":"David","year":"2010","journal-title":"The Lancet"},{"key":"10.1016\/j.lfs.2026.124359_bb0580","first-page":"23","article-title":"Rheumatoid arthritis: pathogenic roles of diverse immune cells","author":"Jang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2026.124359_bb0585","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/cei.13646","article-title":"CD4+LAG-3+ T cells are decreased in active psoriatic arthritis patients and their restorationin vitrois mediated by TNF inhibitors","volume":"206","author":"Gertel","year":"2021","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.lfs.2026.124359_bb0590","article-title":"Type 1 Tregs specific for collagen type II as an efficient cell-based therapy in arthritis","volume":"16","author":"H\u00e9l\u00e8ne Asnagli","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.lfs.2026.124359_bb0595","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature20810","article-title":"Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis","volume":"542","author":"Rao","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2026.124359_bb0600","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2023.2208373","article-title":"Diminished LAG3+ B cells correlate with exacerbated rheumatoid arthritis","volume":"55","author":"Hu","year":"2023","journal-title":"Ann. Med."},{"key":"10.1016\/j.lfs.2026.124359_bb0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2026.104029","article-title":"Precision immunotherapies for systemic lupus erythematosus: from pathogenic targets to translational horizons","author":"Guo","year":"2026","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.lfs.2026.124359_bb0610","first-page":"383","article-title":"Advances in the management of systemic lupus erythematosus","author":"Morand","year":"2023","journal-title":"Bmj"},{"key":"10.1016\/j.lfs.2026.124359_bb0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107028","article-title":"Recent advances in understanding pathogenesis and therapeutic strategies of systemic lupus erythematosus","volume":"89","author":"Luo","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.lfs.2026.124359_bb0620","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/ard-2022-223035","article-title":"Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study","volume":"82","author":"Tian","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.lfs.2026.124359_bb0625","first-page":"6","article-title":"TGF-\u03b23-expressing CD4+CD25\u2212LAG3+ Tregs control humoral immune responses. Nature","author":"Okamura","year":"2015","journal-title":"Communications"},{"key":"10.1016\/j.lfs.2026.124359_bb0630","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1611286114","article-title":"Egr2 and Egr3 in Tregs cooperatively control systemic autoimmunity through Ltbp3-mediated TGF-\u03b23 production","volume":"113","author":"Morita","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.lfs.2026.124359_bb0635","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Tregs and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2026.124359_bb0640","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.coi.2020.10.014","article-title":"Type I interferon in the pathogenesis of systemic lupus erythematosus","volume":"67","author":"Postal","year":"2020","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.lfs.2026.124359_bb0645","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/s41590-022-01152-y","article-title":"Type I interferon transcriptional network regulates expression of coinhibitory receptors in human T cells","volume":"23","author":"Sumida","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.lfs.2026.124359_bb0650","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(18)30481-1","article-title":"Multiple sclerosis","volume":"391","author":"Thompson","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2026.124359_bb0655","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: insights from the atlas of MS, third edition","volume":"26","author":"Walton","year":"2020","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.lfs.2026.124359_bb0660","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/WCO.0000000000000094","article-title":"Relapsing and progressive forms of multiple sclerosis","volume":"27","author":"Dutta","year":"2014","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.lfs.2026.124359_bb0665","first-page":"9","article-title":"Defining the clinical course of multiple sclerosis","volume":"83","author":"Fred","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.lfs.2026.124359_bb0670","doi-asserted-by":"crossref","first-page":"594","DOI":"10.4049\/jimmunol.2100850","article-title":"Fewer LAG-3+ T cells in relapsing-remitting multiple sclerosis and type 1 diabetes","volume":"208","author":"Jones","year":"2022","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2026.124359_bb0675","first-page":"20","article-title":"Blood levels of co-inhibitory-receptors a biomarker of disease prognosis in multiple sclerosis","author":"Iris Lavon","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2026.124359_bb0680","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.msard.2015.11.004","article-title":"Regulatory T cell number in multiple sclerosis patients: a meta-analysis","volume":"5","author":"Noori-Zadeh","year":"2016","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.lfs.2026.124359_bb0685","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/jnr.20522","article-title":"Decreased FOXP3 levels in multiple sclerosis patients","volume":"81","author":"Huan","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.lfs.2026.124359_bb0690","first-page":"3411","article-title":"Patients with relapsing-remitting multiple sclerosis have normal Treg function when cells expressing IL-7 receptor \u03b1-chain are excluded from the analysis","volume":"118","author":"Michel","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2026.124359_bb0695","first-page":"11","article-title":"Multiple sclerosis patients have reduced resting and increased activated CD4+CD25+FOXP3+T regulatory cells","author":"Verma","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2026.124359_bb0700","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/eji.202249845","article-title":"Antigen receptor-engineered Tregs inhibit CNS autoimmunity in cell therapy using nonredundant immune mechanisms in mice","volume":"52","author":"Pohar","year":"2022","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.lfs.2026.124359_bb0705","first-page":"28","article-title":"Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)","volume":"164","author":"Cris","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2026.124359_bb0710","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-023-01289-9","article-title":"Advances in immune checkpoint-based immunotherapies for multiple sclerosis: rationale and practice","volume":"21","author":"Daei Sorkhabi","year":"2023","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.lfs.2026.124359_bb0715","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.immuni.2024.01.010","article-title":"LAG-3, TIM-3, and TIGIT: distinct functions in immune regulation","volume":"57","author":"Joller","year":"2024","journal-title":"Immunity"},{"issue":"13","key":"10.1016\/j.lfs.2026.124359_bb0720","article-title":"Crosstalk between dendritic cells and Tregs: Protective effect and therapeutic potential in multiple sclerosis","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2026.124359_bb0725","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/s41574-023-00853-0","article-title":"Heterogeneity and endotypes in type 1 diabetes mellitus","volume":"19","author":"Redondo","year":"2023","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.lfs.2026.124359_bb0730","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/s41591-021-01418-2","article-title":"100 years of insulin: celebrating the past, present and future of diabetes therapy","volume":"27","author":"Sims","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2026.124359_bb0735","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00320","article-title":"Reversal of new onset type 1 diabetes by Oral Salmonella-based combination therapy and mediated by regulatory T-cells in NOD mice","volume":"10","author":"Mbongue","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2026.124359_bb0740","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.4049\/jimmunol.1100714","article-title":"Cutting edge: accelerated autoimmune diabetes in the absence of LAG-3","volume":"187","author":"Bettini","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2026.124359_bb0745","first-page":"6","article-title":"The effect of low-dose IL-2 and Treg adoptive cell therapy in patients with type 1 diabetes. JCI","author":"Dong","year":"2021","journal-title":"Insight"},{"key":"10.1016\/j.lfs.2026.124359_bb0750","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2147\/ITT.S504555","article-title":"Conversion of T effector cells into T regulatory cells in type 1 diabetes\/latent autoimmune diabetes of adults by inhibiting eIF5A and notch pathways","volume":"14","author":"Rafiqi","year":"2025","journal-title":"ImmunoTargets Ther."},{"key":"10.1016\/j.lfs.2026.124359_bb0755","first-page":"2","article-title":"LAG3 limits regulatory T cell proliferation and function in autoimmune diabetes","author":"Zhang","year":"2017","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.lfs.2026.124359_bb0760","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-025-03502-7","article-title":"LAG3 limits regulatory T cell proliferation in \u03b1-synuclein gut-to-brain transmission model","volume":"22","author":"Kong","year":"2025","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.lfs.2026.124359_bb0765","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1126\/science.1176077","article-title":"Eos mediates Foxp3-dependent gene silencing in CD4+ Tregs","volume":"325","author":"Pan","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.lfs.2026.124359_bb0770","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.immuni.2013.01.013","article-title":"An inherently bifunctional subset of Foxp3+ T helper cells is controlled by the transcription factor Eos","volume":"38","author":"Sharma Madhav","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.lfs.2026.124359_bb0775","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14309\/ajg.0000000000003582","article-title":"Monitoring inflammatory bowel disease activity: when, how, and why","volume":"120","author":"Gaidos","year":"2025","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.lfs.2026.124359_bb0780","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1053\/j.gastro.2023.07.003","article-title":"Incidence, prevalence, and racial and ethnic distribution of inflammatory bowel disease in the United States","volume":"165","author":"Lewis","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2026.124359_bb0785","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.716499","article-title":"Intestinal Tregs as specialized tissue-restricted immune cells in intestinal immune homeostasis and disease","volume":"12","author":"Jacobse","year":"2021","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.lfs.2026.124359_bb0790","article-title":"CD4+CD25-LAG3+ Tregs controlled by the transcription factor Egr-2","volume":"160","author":"Tomohisa Okamura","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.lfs.2026.124359_bb0795","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/mi.2015.45","article-title":"An IL-27\/Lag3 axis enhances Foxp3+ regulatory T cell\u2013suppressive function and therapeutic efficacy","volume":"9","author":"Js","year":"2016","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.lfs.2026.124359_bb0800","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2026.124359_bb0805","article-title":"Advances in psoriasis research: decoding immune circuits and developing novel therapies","volume":"26","author":"Wang","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2026.124359_bb0810","first-page":"12","article-title":"Etanercept downregulates the Th17 pathway and decreases the IL-17+\/IL-10+ cell ratio in patients with psoriasis vulgaris. Journal of","volume":"32","author":"Emiliano Antiga","year":"2012","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.lfs.2026.124359_bb0815","article-title":"Lymphocyte activation gene 3 (LAG-3) modulates the ability of CD4 T-cells to be suppressed in vivo","volume":"9","author":"Kassiotis","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2026.124359_bb0820","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2019.101305","article-title":"Lymphocyte-activation gene 3 (LAG3): the next immune checkpoint receptor","volume":"42","author":"Ruffo","year":"2019","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.lfs.2026.124359_bb0825","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/bjd.19380","article-title":"Role of Tregs in psoriasis pathogenesis and treatment","volume":"184","author":"Nussbaum","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.lfs.2026.124359_bb0830","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/cpt.2091","article-title":"Depletion of LAG-3+ T cells translated to pharmacology and improvement in psoriasis disease activity: a phase I randomized study of mAb GSK2831781","volume":"109","author":"Ellis","year":"2020","journal-title":"Clin. Pharmacol. Ther. (St. Louis, MO, U. S.)"},{"key":"10.1016\/j.lfs.2026.124359_bb0835","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2249.2011.04329.x","article-title":"Antibody-mediated depletion of lymphocyte-activation gene-3 (LAG-3+)-activated T lymphocytes prevents delayed-type hypersensitivity in non-human primates","volume":"164","author":"Poirier","year":"2011","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.lfs.2026.124359_bb0840","doi-asserted-by":"crossref","first-page":"810","DOI":"10.4049\/jimmunol.1900823","article-title":"A LAG-3\u2013Specific Agonist Antibody for the Treatment of T Cell\u2013Induced Autoimmune Diseases","volume":"204","author":"Angin","year":"2020","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2026.124359_bb0845","first-page":"14","article-title":"A randomised, double-blind, placebo-controlled study of the LAG-3-depleting monoclonal antibody GSK2831781 in patients with active ulcerative colitis","volume":"58","author":"Geert D\u2019Haens","year":"2025","journal-title":"Aliment. Pharmacol. Ther."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320526001682?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320526001682?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:12:11Z","timestamp":1778944331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320526001682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":169,"alternative-id":["S0024320526001682"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2026.124359","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LAG-3 at the crossroads: A context-dependent regulator of Tregs and autoimmunity inflammatory disorders","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2026.124359","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124359"}}